Careers
Contact Us
Who We Are
Who We Are
Our History
Mission & Values
Our Team
Leadership
Board of Directors
Careers
ARCUS Genome Editing
ARCUS Genome Editing
Scientific Publications
Pipeline
PBGENE-HBV
Investors
Events & Presentations
Press Releases
Corporate Deck
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Sustainability
Investor FAQs
Partnering
Maurissa Messier
Effective Cell Dose and Functional Attributes of Azercabtagene Zapreleucel (Azer-cel; PBCAR0191) Associated with Allogeneic CAR T-Cell Safety and Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma
by Maurissa Messier
Precise and simultaneous quantification of mitochondrial DNA heteroplasmy and copy number by digital PCR
by Maurissa Messier
AAV-meganuclease-mediated gene targeting achieves efficient and sustained transduction in newborn and infant macaque liver
by Maurissa Messier
Effective Cell Dose and Functional Attributes of Azercabtagene Zapreleucel (azer-cel; PBCAR0191) Associate with Allogeneic CAR T-Cell Safety and Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma
by Maurissa Messier
Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases
by Maurissa Messier
Targeting Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo
by Maurissa Messier
ARCUS gene editing of Apolipoprotein C3 results in substantial reduction in serum triglycerides in vivo
by Maurissa Messier
Specific elimination of m.3243A>G mutant mitochondrial DNA using mitoARCUS in cultured cells and a novel xenograft mouse model
by Maurissa Messier
Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo
by Maurissa Messier
Mitochondrial Targeted Meganuclease as a Platform to Eliminate Mutant mtDNA In Vivo
by Maurissa Messier
Rho 1-2 Meganuclease, an Allele-Specific Gene Editing Therapy, Rejuvenates Rod Photoreceptor Structure and Function in a Pig Model of adRP
by Maurissa Messier
Translation of an AAV-Delivered Gene Editing Approach for Transthyretin Amyloidosis in Animal Models
by Maurissa Messier
Long-Term Stable Reduction of Low-Density Lipoprotein in Nonhuman Primates Following In Vivo Genome Editing of PCSK9
by Maurissa Messier
Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic, Off-the-Shelf CD19-Targeting CAR-T Product, in Relapsed/Refractory (r/r) CD19+ NHL
by Maurissa Messier